The comparison of effects of two drugs in neutropenic patients
Phase 3
- Conditions
- eutropenia.Neutropenia
- Registration Number
- IRCT2017011131878N1
- Lead Sponsor
- Vice chancellor for research, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Solid tumor confirmed by pathology; Children less than 15 years; Parental consent.
Exclusion criteria: Severe infection; Use of Corticosteroid; Sensitivity to filgrastim or pegfilgrastim; Lack of parental consent to continue participating in the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Absolute Neutrophil Count. Timepoint: Before chemotherapy and the first, third, seventh and fourteenth day after Granulocyte Colony Stimulating Factor (GCSF) administration. Method of measurement: Laboratory.
- Secondary Outcome Measures
Name Time Method